BSE 1107.15 NSE 1107.40
Mr. Mark D. McDade

Mr. Mark D. McDade

Independent Director

Mr. McDade is a Co-Founder and Partner at Qiming Venture Partners, USA where he built a strong investment team and made large number of high value investments in biotherapeutics, including cell and gene therapy and digital health.

He is a highly accomplished executive with excellent operating and leadership skills. During a biopharmaceutical career spanning over more than 37 years, he has held a progression of COO and CEO roles in complex businesses. He was most recently the number two executive at UCB Pharma, where he was exceptionally well-regarded and credited with providing steady and resilient leadership during a time of significant transformation. He has a breadth of experience with small and large molecules (biologic) products in a wide range of therapeutic areas. He has a strong track record of developing, launching, scaling and managing commercial products and has consistently delivered above-plan performance. He has extensive experience in all global regions and knows the complex, competitive dynamics in established and emerging markets around the world. His diverse experience with large, mid, small and development-stage companies is unique and provides him with an excellent strategic perspective, which serves him well in a board setting. He has considerable experience serving on the boards of public and private companies and has a very good understanding of governance.

He completed B.A. in History from Dartmouth College and MBA from Harvard Business School.